Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study

BACKGROUND: The role of fibroblast growth factor 23 (FGF23) in the development of new‐onset heart failure (HF) with reduced (HFrEF) or preserved ejection fraction (HFpEF) in the general population is unknown. Therefore, we set out to investigate associations of C‐terminal FGF23 with development of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Binnenmars, S. Heleen, Hoogslag, Georgette E., Yeung, Stanley M. H., Brouwers, Frank P., Bakker, Stephan J. L., van Gilst, Wiek H., Gansevoort, Ron T., Navis, Gerjan, Voors, Adriaan A., de Borst, Martin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375507/
https://www.ncbi.nlm.nih.gov/pubmed/35876420
http://dx.doi.org/10.1161/JAHA.121.024952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375507/
https://www.ncbi.nlm.nih.gov/pubmed/35876420
http://dx.doi.org/10.1161/JAHA.121.024952

Ejemplares similares